| RS2142300348 |
PALB2
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2142300433 |
PALB2
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group N, Fanconi anemia complementation group N |
| RS2142300893 |
ZNF469
|
Health Risk |
Likely pathogenic |
— |
| RS2142301692 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS2142303290 |
MYH2
|
Health Risk |
Likely pathogenic |
— |
| RS2142303605 |
MYH2
|
Health Risk |
Pathogenic |
Myopathy, proximal |
| RS2142303932 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, Ehlers-Danlos syndrome |
| RS2142304720 |
ZNF469
|
Health Risk |
Likely pathogenic |
Brittle cornea syndrome 1, Brittle cornea syndrome 1 |
| RS2142305450 |
MYH2
|
Health Risk |
Pathogenic |
Myopathy, proximal |
| RS2142305562 |
MYH2
|
Health Risk |
Likely pathogenic |
Myopathy, proximal |
| RS2142307505 |
MYO15A
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2142309612 |
MYH2
|
Health Risk |
Pathogenic |
Myopathy, proximal |
| RS2142312393 |
ZNF469
|
Health Risk |
Pathogenic/Likely pathogenic |
Brittle cornea syndrome 1, Brittle cornea syndrome 1 |
| RS2142314304 |
ZNF469
|
Health Risk |
Pathogenic |
Brittle cornea syndrome 1, Brittle cornea syndrome 1 |
| RS2142314561 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2142314789 |
EPB42
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 5, Hereditary spherocytosis type 5 |
| RS2142315607 |
MYO15A
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2142315894 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2142318412 |
MYH2
|
Health Risk |
Likely pathogenic |
Myopathy, proximal |
| RS2142319855 |
MYH2
|
Health Risk |
Likely pathogenic |
Myopathy, proximal |
| RS2142325910 |
PALB2
|
Health Risk |
Likely pathogenic |
Pancreatic cancer, susceptibility to |
| RS2142325956 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2142326062 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2142326183 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2142326522 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2142326602 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2142326815 |
PALB2
|
Health Risk |
Likely pathogenic |
Breast carcinoma, Breast carcinoma |
| RS2142327117 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2142327301 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2142328201 |
MYO15A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2142328321 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2142328421 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2142330705 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2142330998 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2142334166 |
PALB2
|
Health Risk |
Likely pathogenic |
— |
| RS2142334914 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2142334934 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2142335605 |
MYO15A
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2142336574 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2142337034 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2142341338 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2142341398 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2142343280 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2142343437 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2142343642 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2142344237 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary breast ovarian cancer syndrome |
| RS2142347739 |
MYO15A
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2142349089 |
MMP2
|
Health Risk |
Pathogenic |
Multicentric osteolysis nodulosis arthropathy spectrum, Multicentric osteolysis nodulosis arthropathy spectrum |
| RS2142353165 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2142353580 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2142353661 |
MMP2
|
Health Risk |
Pathogenic |
Multicentric osteolysis nodulosis arthropathy spectrum, Multicentric osteolysis nodulosis arthropathy spectrum |
| RS2142353982 |
IRX5
|
Health Risk |
Pathogenic |
Craniofacial dysplasia - osteopenia syndrome, Craniofacial dysplasia - osteopenia syndrome |
| RS2142354911 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2142355107 |
MYO15A
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2142355316 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2142355636 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2142356386 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2142356956 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Familial cancer of breast |
| RS2142358692 |
MMP2
|
Health Risk |
Pathogenic |
Multicentric osteolysis, nodulosis |
| RS2142358933 |
MMP2
|
Health Risk |
Pathogenic |
Multicentric osteolysis, nodulosis |
| RS2142360420 |
MYO15A
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2142360575 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2142362830 |
MYO15A
|
Health Risk |
Likely pathogenic |
— |
| RS2142363190 |
MYO15A
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2142363296 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2142364249 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2142364275 |
CLCN7
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant osteopetrosis 2, Autosomal recessive osteopetrosis 4 |
| RS2142365554 |
CLCN7
|
Health Risk |
Likely pathogenic |
— |
| RS2142366086 |
CLCN7
|
Health Risk |
Pathogenic |
— |
| RS2142366092 |
CLCN7
|
Health Risk |
Pathogenic |
Autosomal dominant osteopetrosis 2, Autosomal dominant osteopetrosis 2 |
| RS2142366157 |
CLCN7
|
Health Risk |
Likely pathogenic |
Disorder of bone, Disorder of bone |
| RS2142367705 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2142367858 |
PALB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Malignant tumor of breast, Familial cancer of breast |
| RS2142368283 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2142368459 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2142368508 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2142368926 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2142368980 |
CLCN7
|
Health Risk |
Likely pathogenic |
Autosomal recessive osteopetrosis 4, Autosomal recessive osteopetrosis 4 |
| RS2142369409 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2142370409 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2142370684 |
MYO15A
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2142371207 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2142372943 |
CLCN7
|
Health Risk |
Pathogenic |
— |
| RS2142373200 |
KIF22
|
Health Risk |
Likely pathogenic |
Spondyloepimetaphyseal dysplasia with multiple dislocations, Spondyloepimetaphyseal dysplasia with multiple dislocations |
| RS2142373865 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2142374295 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2142374547 |
CLCN7
|
Health Risk |
Likely pathogenic |
— |
| RS2142374794 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2142374907 |
PALB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2142376390 |
MYO15A
|
Health Risk |
Pathogenic |
Papillary renal cell carcinoma type 1, Papillary renal cell carcinoma type 1 |
| RS2142377240 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2142377985 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2142377997 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2142378398 |
CLCN7
|
Health Risk |
Likely pathogenic |
Autosomal dominant osteopetrosis 2, Hypopigmentation |
| RS2142378539 |
CLCN7
|
Health Risk |
Likely pathogenic |
Autosomal dominant osteopetrosis 2, Autosomal dominant osteopetrosis 2 |
| RS2142379081 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2142379245 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2142379352 |
CLCN7
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2142379446 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2142379886 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |